Contrast-induced acute kidney injury: Is there a risk after intravenous contrast?

Clinical Journal of the American Society of Nephrology

Volumn 3, Issue 5, 2008, Pages 1242-1243

  Solomon, Richard ^a,b  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b FLETCHER ALLEN HEALTH CARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; CREATININE;

ACUTE KIDNEY FAILURE; BLOOD; CHEMICALLY INDUCED DISORDER; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECT; EDITORIAL; GLOMERULUS FILTRATION RATE; HOSPITAL PATIENT; HUMAN; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; OUTPATIENT; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; TIME;

CONTRAST MEDIA; CREATININE; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; INJECTIONS, INTRAVENOUS; INPATIENTS; KIDNEY; OUTPATIENTS; RENAL DIALYSIS; RENAL INSUFFICIENCY, ACUTE; RISK ASSESSMENT; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 53749093136     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03470708     Document Type: Editorial

References (10)

1. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, Ting HH, Best PJ, Singh M, Bell MR, Barsness GW, Mathew V, Garratt KN, Holmes DR Jr: Incidence and prognostic importance of acute renal failure after percutaneous coronary interven tion. Circulation 105: 2259-2264,2002
2. Gruberg L, Mintz GS, Mehran R, Gangas G, Lansky AJ, Kent KM, Pichard AD, Satler LF, Leon MB: The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 36: 1542-1548, 2000
3. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW: Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am J Med 103: 368-375, 1997
4. Weisbord SD, Mor MK, Resnick AL, Hartwig KC, Palevsky PM, Fine MJ: Incidence and outcomes of contrast-induced AKI following computed tomography. Clin J Am Soc Nephrol 3: 1274-1281, 2008
5. Katzberg RW, Barrett BJ: Risk of iodinated contrast material-induced nephropathy with intravenous administration. Radiology 243: 622-628, 2007
6. Barrett B, Thomsen H, Katzberg R: Nephrotoxicity of low-osmolar iopamidol vs iso-osmolar iodixanol in renally impaired patients: The IMPACT study. Invest Radiol 41: 815-821, 2006
7. Thomsen HS, Morcos SK, Erley CM, Grazioli L, Bonomo L, Ni Z, Romano L, Invesfigators in the Abdominal Computed Tomography: The ACTIVE trial: Comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography. Invest Radio 43: 170-178, 2008
8. Kuhn M, Chen N, Sahani DV, Reimer D, van Beek EJ, Heiken JP, So GJ: The PREDICT study: A randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure. Am J Radiol 191: 151-157, 2008
9. Levy EM, Viscoli CM, Horwitz RI: The effect of acute renal failure on mortality: A cohort analysis. JAMA 275: 1489-1494, 1996
10. Sherwin PF, Cambron R, Johnson JA, Pierro JA: Contrast dose-to-creatinine clearance ratio as a potential indicator of risk for radiocontrast-induced nephropathy: Correlation of D/CrCl with area under the contrast concentration-time curve using iodixanol. Invest Radiol 40: 598-603, 2005